Drug Topics
CONTINUE TO SITE >

OR WAIT 15 SECS

Merck Moves Forward with Plans for Vorapaxar Approval

November 1, 2012

Anticoagulation therapies reviewed, including Merck moving forward with FDA approval of vorapaxar despite bleeding risks